Latest Insider Transactions at West Pharmaceutical Services Inc (WST)
This section provides a real-time view of insider transactions for West Pharmaceutical Services Inc (WST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WEST PHARMACEUTICAL SERVICES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WEST PHARMACEUTICAL SERVICES INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 11
2023
|
Quintin J Lai VP Strat & Investor Relations |
SELL
Open market or private sale
|
Direct |
21,101
-22.0%
|
$8,334,895
$395.43 P/Share
|
Aug 11
2023
|
Quintin J Lai VP Strat & Investor Relations |
BUY
Exercise of conversion of derivative security
|
Direct |
21,101
+10.9%
|
$4,241,301
$201.76 P/Share
|
Aug 09
2023
|
Charles Witherspoon VP & Treasurer |
SELL
Open market or private sale
|
Direct |
1,680
-47.88%
|
$665,280
$396.54 P/Share
|
Aug 09
2023
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,680
+21.63%
|
$230,160
$137.87 P/Share
|
Aug 08
2023
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,160
-33.03%
|
$3,239,520
$397.43 P/Share
|
Aug 08
2023
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,160
+39.75%
|
$832,320
$102.51 P/Share
|
Aug 08
2023
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
44,000
-2.96%
|
$17,336,000
$394.91 P/Share
|
Aug 08
2023
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+21.32%
|
$2,850,000
$57.38 P/Share
|
Aug 02
2023
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
SELL
Open market or private sale
|
Direct |
22,334
-43.64%
|
$8,263,580
$370.7 P/Share
|
Aug 02
2023
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
BUY
Exercise of conversion of derivative security
|
Direct |
22,334
+36.97%
|
$2,255,734
$101.72 P/Share
|
May 30
2023
|
Chad Winters VP, Chief Accounting Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
872
-37.59%
|
$295,608
$339.51 P/Share
|
May 30
2023
|
Chad Winters VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
872
+27.32%
|
$124,696
$143.43 P/Share
|
May 30
2023
|
Charles Witherspoon VP & Treasurer |
SELL
Open market or private sale
|
Direct |
1,000
-35.35%
|
$343,000
$343.05 P/Share
|
May 30
2023
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+26.12%
|
$102,000
$102.51 P/Share
|
May 09
2023
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
44,000
-5.45%
|
$15,972,000
$363.81 P/Share
|
May 09
2023
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+21.87%
|
$2,850,000
$57.38 P/Share
|
May 05
2023
|
Chad Winters VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.69%
|
$3,680
$368.46 P/Share
|
May 01
2023
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,020
-36.82%
|
$2,927,300
$365.85 P/Share
|
May 01
2023
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,020
+39.61%
|
$689,720
$86.24 P/Share
|
May 01
2023
|
Thomas W Hofmann Director |
SELL
Open market or private sale
|
Direct |
1,212
-2.7%
|
$442,380
$365.57 P/Share
|
May 01
2023
|
Annette F Favorite Sr. VP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
13,012
-18.02%
|
$4,762,392
$366.46 P/Share
|
May 01
2023
|
Annette F Favorite Sr. VP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,012
+31.81%
|
$767,708
$59.64 P/Share
|
Apr 25
2023
|
Thomas W Hofmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+1.36%
|
-
|
Apr 25
2023
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+36.54%
|
-
|
Apr 25
2023
|
Mark A Buthman Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+1.47%
|
-
|
Apr 25
2023
|
Molly Joseph Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+33.05%
|
-
|
Apr 25
2023
|
Goldman Myla Lai Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+3.35%
|
-
|
Apr 25
2023
|
Paolo Pucci Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+6.21%
|
-
|
Apr 25
2023
|
Robert F Friel Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+16.82%
|
-
|
Apr 25
2023
|
Deborah L Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+6.39%
|
-
|
Apr 25
2023
|
Douglas A Michels Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+1.4%
|
-
|
Apr 25
2023
|
William F Feehery Director |
BUY
Grant, award, or other acquisition
|
Direct |
616
+2.03%
|
-
|
Mar 09
2023
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,500
-26.27%
|
$483,000
$322.57 P/Share
|
Mar 07
2023
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
44,000
-7.64%
|
$14,168,000
$322.47 P/Share
|
Mar 07
2023
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.92%
|
$2,850,000
$57.38 P/Share
|
Mar 01
2023
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
234
+3.94%
|
$74,412
$318.28 P/Share
|
Mar 01
2023
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
SELL
Grant, award, or other acquisition
|
Direct |
43
-0.98%
|
$13,674
$318.28 P/Share
|
Feb 21
2023
|
Chad Winters VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
476
+24.61%
|
$145,656
$306.68 P/Share
|
Feb 21
2023
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
BUY
Grant, award, or other acquisition
|
Direct |
3,614
+45.05%
|
$1,105,884
$306.68 P/Share
|
Feb 21
2023
|
Quintin J Lai VP Strat & Investor Relations |
BUY
Grant, award, or other acquisition
|
Direct |
1,134
+5.83%
|
$347,004
$306.68 P/Share
|
Feb 21
2023
|
Annette F Favorite Sr. VP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,740
+10.47%
|
$532,440
$306.68 P/Share
|
Feb 21
2023
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,274
+29.35%
|
$695,844
$306.68 P/Share
|
Feb 21
2023
|
Kimberly Banks Mac Kay SVP, GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
327
+33.92%
|
$100,062
$306.68 P/Share
|
Feb 21
2023
|
Cindy Reiss Clark Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
970
+18.34%
|
$296,820
$306.68 P/Share
|
Feb 21
2023
|
Charles Witherspoon VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
407
+18.2%
|
$124,542
$306.68 P/Share
|
Feb 21
2023
|
Eric Mark Green President, CEO and Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
14,783
+10.23%
|
$4,523,598
$306.68 P/Share
|
Dec 05
2022
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
44,000
-5.23%
|
$10,516,000
$239.22 P/Share
|
Dec 05
2022
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+23.93%
|
$2,850,000
$57.38 P/Share
|
Oct 31
2022
|
Chad Winters VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47
-4.57%
|
$10,575
$225.51 P/Share
|
Aug 02
2022
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
SELL
Open market or private sale
|
Direct |
14,174
-50.61%
|
$4,847,508
$342.11 P/Share
|